Capricor, a privately-held biotechnology company treating cardiac patients, is adding Anthony Davies as its newly-minted CTO. The company is based in Los Angeles.
PRESS RELEASE:
Capricor, Inc., a privately held biotechnology company whose cardiac-derived stem cells (CDCs) are being studied as a potentially novel treatment to repair the heart following large heart attacks, announced today that it has appointed Anthony Davies, Ph.D.,
